Business Ideas

ADRs gain $11 bn in September

Indian stocks trading on American bourses gained about $11 billion in one month, with IT bellwether Infosys and private sector lender HDFC Bank accounting almost half of the gains. For the month ended September 30, Indian entities listed on the New York Stock Exchange and Nasdaq added $10.61 billion to their market-cap, with Infosys and HDFC Bank together contributing $5.82 billion. - US markets end down; ICICI Bank soars 6% - US markets end marginally lower - US markets edge up on M&A deals - US markets slip for third day - US markets slip on weak data, stimulus worries - US markets slip on stimulus withdrawal worries Infosys’ valuation grew by $3.01 billion, while that of HDFC Bank rose by $2.81 billion. The market capitalisation of ICICI Bank jumped by $1.87 billion. PTI while copper producer Sterlite Industries saw an increase of $1.82 billion to its valuations. Among the 16 companies trading as American Depository Receipts (ADRs), another major gainer was pharma major Dr Reddy’s Laboratories whose market capitalisation increased by $570 million. Apart from Infosys, HDFC Bank, ICICI Bank, Sterlite Industries and Dr Reddy’s Laboratories, IT major Wipro too witnessed a significant increase to its market capitalisation. The company saw an increase of $322 million to its valuation. ADRs are bought and sold on American bourses just like stocks and are issued by banks or brokerage firms.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
No proposal to extend trading beyond 1530 hrs: NSE chief
Facing opposition from a section of brokers for advancing opening of the stock market by an hour, the National Stock Exchange (NSE) today said it would not allow trading beyond scheduled 1530 hours.
Popular Articles

'Monetary tightening will cause some pullback'
Abhineet Kumar & Sidhartha / Mumbai December 31, 2009, 0:26 IST

Omaxe, Great Eastern Shipping & Nalco Q1 result
Omaxe net dips 73.6% Real estate player Omaxe on Friday reported 73.6 per cent decline in its consolidated net profit for the quarter ended June 30 at Rs 14.96 crore as against Rs 56.67 crore in the year-ago period. The consolidated net profit during the first quarter also dipped 66.06 per cent to Rs 118.91 crore from Rs 350.33 crore in the same period last year, the company said in a statement.